ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
- Written by PR Newswire
![]() |
TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyte™. The announcement coincides with the 2025 Society for Laboratory...















